Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PTPN22 is not associated with Behçet's disease. Study spanning the complete gene region in the Spanish population and meta-analysis of the functional variant R620W.
Ortiz-Fernández L, Montes-Cano MA, García-Lozano JR, Conde-Jaldón M, Ortego-Centeno N, González-Leon R, Espinosa G, Graña-Gil G, Sánchez-Bursón J, Juliá MR, Solans R, Blanco R, Barnosi-Marín AC, Fanlo P, Rodríguez Carballeira M, Camps MT, Castañeda S, Martín J, González-Escribano MF. Ortiz-Fernández L, et al. Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):S41-S45. Epub 2016 Apr 1. Clin Exp Rheumatol. 2016. PMID: 27050764
IL2/IL21 region polymorphism influences response to rituximab in systemic lupus erythematosus patients.
Márquez A, Dávila-Fajardo CL, Robledo G, Rubio JL, de Ramón Garrido E, García-Hernández FJ, González-León R, Ríos-Fernández R, Barrera JC, González-Escribano MF, García MT, Palma MJ, del Mar Ayala M, Ortego-Centeno N, Martín J. Márquez A, et al. Mol Biol Rep. 2013 Aug;40(8):4851-6. doi: 10.1007/s11033-013-2583-6. Epub 2013 May 5. Mol Biol Rep. 2013. PMID: 23645042
Epistatic interaction of ERAP1 and HLA-B in Behçet disease: a replication study in the Spanish population.
Conde-Jaldón M, Montes-Cano MA, García-Lozano JR, Ortiz-Fernández L, Ortego-Centeno N, González-León R, Espinosa G, Graña-Gil G, Sánchez-Bursón J, González-Gay MA, Barnosi-Marín AC, Solans R, Fanlo P, Carballeira MR, Camps T, Castañeda S, Martín J, González-Escribano MF. Conde-Jaldón M, et al. PLoS One. 2014 Jul 14;9(7):e102100. doi: 10.1371/journal.pone.0102100. eCollection 2014. PLoS One. 2014. PMID: 25019531 Free PMC article.
Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus.
Ruiz-Irastorza G, García M, Espinosa G, Cabezas-Rodríguez I, Mitjavila F, González-León R, Sopeña B, Perales I, Pinilla B, Rodríguez-Carballeira M, López-Dupla JM, Callejas JL, Castro A, Tolosa C, Sánchez-García ME, Pérez-Conesa M, Navarrete-Navarrete N, Rodríguez AP, Herranz MT, Pallarés L; RELES, Autoimmune Diseases Study Group GEAS. Ruiz-Irastorza G, et al. Clin Exp Rheumatol. 2016 May-Jun;34(3):466-72. Epub 2016 Feb 26. Clin Exp Rheumatol. 2016. PMID: 26940538
First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort.
Ruiz-Irastorza G, Garcia M, Espinosa G, Caminal L, Mitjavila F, González-León R, Sopeña B, Canora J, Villalba MV, Rodríguez-Carballeira M, López-Dupla JM, Callejas JL, Castro A, Tolosa C, Sánchez-García ME, Pérez-Conesa M, Navarrete-Navarrete N, Rodríguez AP, Herranz MT, Pallarés L. Ruiz-Irastorza G, et al. Lupus Sci Med. 2016 Aug 2;3(1):e000153. doi: 10.1136/lupus-2016-000153. eCollection 2016. Lupus Sci Med. 2016. PMID: 27547439 Free PMC article.
First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.
Rubio-Rivas M, Corbella X, Pestaña-Fernández M, Tolosa-Vilella C, Guillen-Del Castillo A, Colunga-Argüelles D, Trapiella-Martínez L, Iniesta-Arandia N, Castillo-Palma MJ, Sáez-Comet L, Egurbide-Arberas MV, Ortego-Centeno N, Freire M, Vargas-Hitos JA, Ríos-Blanco JJ, Todolí-Parra JA, Rodríguez-Carballeira M, Marín-Ballvé A, Segovia-Alonso P, Pla-Salas X, Madroñero-Vuelta AB, Ruiz-Muñoz M, Fonollosa-Pla V, Simeón-Aznar CP; RESCLE investigators, Autoimmune Diseases Study Group (GEAS); Callejas Moraga E, Calvo E, Carbonell C, Castillo MJ, Chamorro AJ, Colunga D, Corbella X, Egurbide MV, Espinosa G, Fonollosa V, Freire M, García Hernández FJ, González León R, Guillén Del Castillo A, Iniesta N, Lorenzo R, Madroñero AB, Marí B, Marín A, Ortego-Centeno N, Pérez Conesa M, Pestaña M, Pla X, Ríos Blanco JJ, Rodríguez Carballeira M, Rubio Rivas M, Ruiz Muñoz M, Sáez Comet L, Segovia P, Simeón CP, Soto A, Tarí E, Todolí JA, Tolosa C, Trapiella L, Vargas Hitos JA, Verdejo G. Rubio-Rivas M, et al. Among authors: gonzalez leon r. Clin Rheumatol. 2018 Apr;37(4):999-1009. doi: 10.1007/s10067-017-3936-7. Epub 2017 Dec 7. Clin Rheumatol. 2018. PMID: 29214548
Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
González-Echavarri C, Capdevila O, Espinosa G, Suárez S, Marín-Ballvé A, González-León R, Rodríguez-Carballeira M, Fonseca-Aizpuru E, Pinilla B, Pallarés L, Ruiz-Irastorza G; RELES, Autoimmune Diseases Study Group GEAS. González-Echavarri C, et al. Among authors: gonzalez leon r. Lupus. 2018 Dec;27(14):2253-2261. doi: 10.1177/0961203318811598. Lupus. 2018. PMID: 30451641
Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus.
Prevete I, Espinosa G, Bellisai F, Bortoluzzi A, Conti F, Fredi M, Fonseca-Aizpuru EM, García de Viedma V, González-García A, González-León R, Iaccarino L, Iannone F, Marín-Ballvé A, Mitjavila F, Pallarés L, Piga M, Ríos-Garcés R, Suárez S, Tani C, Zanetti A, Ruiz-Irastorza G, Sebastiani GD; Gruppo di Studio SIR sul Lupus Eritematoso Sistemico di recente insorgenza-Early Lupus and Registro Español de pacientes con Lupus Eritematoso Sistémico (RELES), Autoimmune Diseases Study Group (GEAS). Prevete I, et al. Among authors: gonzalez leon r. Clin Exp Rheumatol. 2020 Sep-Oct;38(5):925-932. Epub 2020 Jan 20. Clin Exp Rheumatol. 2020. PMID: 31969225 Free article.
Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label.
Díaz-Lagares C, Pérez-Alvarez R, García-Hernández FJ, Ayala-Gutiérrez MM, Callejas JL, Martínez-Berriotxoa A, Rascón J, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Gómez-de-la-Torre R, Sáez L, Canora-Lebrato J, Camps MT, Ortego-Centeno N, Castillo-Palma MJ, Ramos-Casals M; BIOGEAS Study Group. Díaz-Lagares C, et al. Arthritis Res Ther. 2011 Jul 11;13(4):R112. doi: 10.1186/ar3397. Arthritis Res Ther. 2011. PMID: 21745378 Free PMC article.
Clinical characteristics during diagnosis of a prospective cohort of patients with systemic lupus erythematosus treated in Spanish Departments of Internal Medicine: The RELES study.
Canora J, García M, Mitjavila F, Espinosa G, Suárez S, González-León R, Sopeña B, Boldova R, Castro A, Ruiz-Irastorza G; en representación de los investigadores del Registro RELES-Grupo de Enfermedades Autoinmunes Sistémicas (GEAS). Canora J, et al. Among authors: gonzalez leon r. Rev Clin Esp (Barc). 2017 Jan-Feb;217(1):7-14. doi: 10.1016/j.rce.2016.09.006. Epub 2016 Oct 25. Rev Clin Esp (Barc). 2017. PMID: 27793331 English, Spanish.
40 results